Skip to content

Comparative Study Between the Effect of Diclofanic and Ketorolac in Post Tonsillectomy Pain Management

Comparative Study Between the Effect of Diclofanic and Ketorolac in Post Tonsillectomy Pain Management

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03178539
Enrollment
100
Registered
2017-06-07
Start date
2017-01-31
Completion date
2018-12-31
Last updated
2020-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Acute

Keywords

tonsillectomy, post operative analgesia, diklofanic, ketorolac

Brief summary

Compare between the analgesic efficacy of diclofenac sodium and ketorolac tromethamine in post-tonsillectomy pain management.and Compare between the effect of diclofenac sodium and ketorolac tromethamine on post-tonsillectomy bleeding

Detailed description

patients will be randomly allocated to two groups of 50 patients each Group (A): will receive intra-operative diclofenac sodium at dose of 0.3 mg/kg intravenously. Group (B): will receive intra-operative ketorolac tromethamine at dose of 0.5 mg/kg intravenously. Then the two groups will continue postoperatively on the same drug received intra-operative I. Intra-operative data: Bleeding score will be assessed by the surgeon at the end of the operation using the following Scale for bleeding assessment (0 = no bleeding, 1 = bleeding as usual, 2 = bleeding more than usual, 3 = profuse, 4 = excessive, and lastly 5 = excessive and continuous). II. Early Post-operative data: 1. Post- tonsillectomy bleeding assessments; * Bleeding score will be recorded immediately postoperative and 3, 6, 12 and 24h postoperatively. * Hospital re-admission because of bleeding. * Re-operation because of bleeding. 2. Post- tonsillectomy pain assessments; Pain intensity will be assessed postoperatively by the verbal rating scale (VRS; 0 = no pain, 1 = mild pain, 2 = moderate pain, 3= severe pain, and lastly 4= excruciating pain). VRS assessment will be performed immediately postoperative and 3, 6, 12 and 24h postoperatively. Analgesia will be given if requested or if the VRS≥3. Patients in Group A will receive diclofenac sodium 0.3 mg/kg iv, while patients in Group B will receive ketorolac tromethamine 0.5 mg/kg. The total consumption of analgesics used in each group in the first 24 h postoperative will be calculated and the time of the first request for analgesia will be recorded. \- Time needed to restore normal dietary habits. IV. Late Post-operative data: As aweekly follow up for 2 weeks : 1. bleeding tendency 2. Dysphagia. * Time needed to restore normal dietary habits

Interventions

DRUGdiclofenac

non steroidal anti-inflammatory drug

DRUGketorolac

non steroidal anti-inflammatory drug

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children scheduled for elective tonsillectomy\\adenotnsillectomy for chronic or recurrent tonsillitis and aged between 6 to 12 years

Exclusion criteria

* Known hypersensitivity to medication drugs. * Coagulation disorders, thrombocytopenia or active bleeding for any cause. * Bronchial asthma. * Significant cardiac, renal, pulmonary, hepatic disease or peptic ulcer. * The use of any analgesic medications within 24h preoperative or antiplatelet medication within the past 2 weeks.

Design outcomes

Primary

MeasureTime frameDescription
pain relieve24 hoursthe verbal rating scale (VRS; 0 = no pain, 1 = mild pain, 2 = moderate pain, 3= severe pain, and lastly 4= excruciating pain). VRS assessment will be performed immediately postoperative and 3, 6, 12 and 24h postoperatively

Secondary

MeasureTime frameDescription
bleedingtwo weeksBleeding score will be assessed by the surgeon at the end of the operation using the following Scale for bleeding assessment (0 = no bleeding, 1 = bleeding as usual, 2 = bleeding more than usual, 3 = profuse, 4 = excessive, and lastly 5 = excessive and continuous).
dysphagiatwo weekstime needed to restore normal dietary habbit

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026